168 related articles for article (PubMed ID: 23623871)
1. MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.
Diniz GP; Takano AP; Barreto-Chaves ML
Mol Cell Endocrinol; 2013 Jul; 374(1-2):117-24. PubMed ID: 23623871
[TBL] [Abstract][Full Text] [Related]
2. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.
Diniz GP; Lino CA; Guedes EC; Moreira Ldo N; Barreto-Chaves ML
Basic Res Cardiol; 2015 Sep; 110(5):49. PubMed ID: 26202011
[TBL] [Abstract][Full Text] [Related]
3. AT1 receptor blockage impairs NF-κB activation mediated by thyroid hormone in cardiomyocytes.
Takano APC; Senger N; Munhoz CD; Barreto-Chaves MLM
Pflugers Arch; 2018 Mar; 470(3):549-558. PubMed ID: 29178049
[TBL] [Abstract][Full Text] [Related]
4. Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium.
Rawal S; Nagesh PT; Coffey S; Van Hout I; Galvin IF; Bunton RW; Davis P; Williams MJA; Katare R
Cardiovasc Diabetol; 2019 Jan; 18(1):13. PubMed ID: 30696455
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.
Callis TE; Pandya K; Seok HY; Tang RH; Tatsuguchi M; Huang ZP; Chen JF; Deng Z; Gunn B; Shumate J; Willis MS; Selzman CH; Wang DZ
J Clin Invest; 2009 Sep; 119(9):2772-86. PubMed ID: 19726871
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone.
Diniz GP; Lino CA; Moreno CR; Senger N; Barreto-Chaves MLM
J Cell Physiol; 2017 Dec; 232(12):3360-3368. PubMed ID: 28063219
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of miR-208a in the heart.
Oliveira-Carvalho V; Carvalho VO; Bocchi EA
DNA Cell Biol; 2013 Jan; 32(1):8-12. PubMed ID: 23121236
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system.
Araujo AS; Diniz GP; Seibel FE; Branchini G; Ribeiro MF; Brum IS; Khaper N; Barreto-Chaves ML; Belló-Klein A
Mol Cell Endocrinol; 2011 Feb; 333(1):78-84. PubMed ID: 21168472
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cardiac miR-208a, an inducer of obesity, by rapamycin and nebivolol.
Gul R; Mahmood A; Luck C; Lum-Naihe K; Alfadda AA; Speth RC; Pulakat L
Obesity (Silver Spring); 2015 Nov; 23(11):2251-9. PubMed ID: 26381051
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes.
Nishi H; Ono K; Horie T; Nagao K; Kinoshita M; Kuwabara Y; Watanabe S; Takaya T; Tamaki Y; Takanabe-Mori R; Wada H; Hasegawa K; Iwanaga Y; Kawamura T; Kita T; Kimura T
Mol Cell Biol; 2011 Feb; 31(4):744-55. PubMed ID: 21149577
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice.
Azibani F; Devaux Y; Coutance G; Schlossarek S; Polidano E; Fazal L; Merval R; Carrier L; Solal AC; Chatziantoniou C; Launay JM; Samuel JL; Delcayre C
PLoS One; 2012; 7(5):e38197. PubMed ID: 22666483
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
[TBL] [Abstract][Full Text] [Related]
13. Ambient air PM
Bai L; Zhao Y; Zhao L; Zhang M; Cai Z; Yung KKL; Dong C; Li R
Environ Toxicol Pharmacol; 2021 Jul; 85():103653. PubMed ID: 33812011
[TBL] [Abstract][Full Text] [Related]
14. New insight into the mechanisms associated with the rapid effect of T₃ on AT1R expression.
Diniz GP; Takano AP; Bruneto E; Silva FG; Nunes MT; Barreto-Chaves ML
J Mol Endocrinol; 2012 Aug; 49(1):11-20. PubMed ID: 22525353
[TBL] [Abstract][Full Text] [Related]
15. Beta-arrestin 2 mediates cardiac hypertrophy induced by thyroid hormones via AT1R.
Lino CA; de Bortoli Teixeira L; Capelupe Simões S; de Oliveira Silva T; Diniz GP; da Costa-Neto CM; Barreto-Chaves MLM
J Cell Physiol; 2021 Jun; 236(6):4640-4654. PubMed ID: 33345322
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin proteasome system (UPS) activation in the cardiac hypertrophy of hyperthyroidism.
Lino CA; Demasi M; Barreto-Chaves ML
Mol Cell Endocrinol; 2019 Aug; 493():110451. PubMed ID: 31112742
[TBL] [Abstract][Full Text] [Related]
17. Exercise training prevents obesity-associated disorders: Role of miRNA-208a and MED13.
Fernandes T; Barretti DL; Phillips MI; Menezes Oliveira E
Mol Cell Endocrinol; 2018 Nov; 476():148-154. PubMed ID: 29746886
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW; Li Q; Lin L; Wang XC; Li DF; Wang GK; Ren AJ; Wang YR; Qin YW; Yuan WJ; Jing Q
J Cell Physiol; 2010 Nov; 225(2):437-43. PubMed ID: 20458739
[TBL] [Abstract][Full Text] [Related]
19. Decreased PGC1- α levels and increased apoptotic protein signaling are associated with the maladaptive cardiac hypertrophy in hyperthyroidism.
Teixeira RB; Barboza TE; DE Araujo CC; Siqueira R; DE Castro AL; Bonetto JHP; DE Lima-Seolin BG; Carraro CC; Bello-Klein A; Singal PK; Araujo ASDR
J Biosci; 2018 Dec; 43(5):887-895. PubMed ID: 30541949
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
